Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims Database.

M Elaine Husni Eunice Chang Michael S Broder Caleb Paydar Katalin BognarPooja DesaiYuri KlyachkinIbrahim Khilfeh

Published in: Open access rheumatology : research and reviews (2022)

Systemic-naïve patients with PsA have a lower rate of, and longer time to, biologic initiation over one-year following APR initiation, compared to those initiating MTX.

Keyphrases

rheumatoid arthritis
end stage renal disease
prostate cancer
ejection fraction
newly diagnosed
chronic kidney disease
high dose
health insurance
low dose
combination therapy
replacement therapy
patient reported